But seriously, I can see why the hypothesis was appealing - all it takes is to reduce a-beta levels in the periphery with an antibody or a BACE1 inhibitor, no need to penetrate the BBB to hit the target - decreasing deposited a-beta in the brain.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.